References
- Goh, K. L. (2004) Changing epidermaology of gastro esophageal reflux disease in the Asian-Pacific region: An overview. J. Gasroenterol. Hepatol. 19: S22-S25. https://doi.org/10.1111/j.1440-1746.2004.03591.x
- Mullin, J. M., M. Gabello, L. J. Murray, C. P. Farrell, J. Bellows, K. R. Wolov, K. R. Kearney, D. Rudolph, and J. J. Thornton (2009) Proton pump inhibitors: actions and reactions. Drug Discov. Today 14: 647-660. https://doi.org/10.1016/j.drudis.2009.03.014
- Kim, J. H., J. G. Oh, G. S. Khang, J. K. Jeong, J. S. Lee, S. Y. Jeung and H. B. Lee (2002) The effect of sodium alginate coating on the storage stability and dissolution rate of enteric coated Lansoprazole. J. Kor. Pharm. Sci. 32: 277-284.
-
Bisws, B. K., M. S. Islam, F. Begum, and A. S. S. Rouf (2008) In vitro release kinetic study of esomeprazole magnesium from methocel
$K_{15}M$ and methocel$K_{100}$ LVCR matrix tablets. Dhaka Univ. J. Pharm. Sci. 7: 39-45. - Richter, J. E., P. J. Kahrilas, J. Johanson, P. Maton, J. R. Breiter, C. Hwang, V. Marino, B. Hamelin, J. G. Levine (2001) Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am. J. Gastroenterol. 96: 656-665. https://doi.org/10.1111/j.1572-0241.2001.03600.x
- Kristl, A. and F. Vrecer (2000) Preformulation investigation of th novel proton pump inhibitor lansoprazole. Drug Dev. Ind. Pharm. 26: 781-783. https://doi.org/10.1081/DDC-100101299
- Baradell, L. B., D. Faulds, and D. McTavish (1992) Lansoprazole: A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs. 44: 225-250. https://doi.org/10.2165/00003495-199244020-00007
- Jeong, S. H. (2007) The implication of incrementally modified drug technology and the current trends in psychopharmacology. Korean J. Psychopharmacol. 18: 373-383.
- Kim, J. J., S. Y. Lee, P. L. Rhee, S. J. Myung, J. H. Kim, M. Y. Gyu, S. Y. Kim, O. Y. Lee, J. S. Rew, Y. E. Joo, S. C. Choi, T. H. Kim, S. K. Kim, H. Y. Jeong, B. S. Lee, D. H. Kang, J. Y. Koo, and J. C. Rhee (2003) Multicenter study to evaluate the effect of esomeprazole in Gastro-esophageal reflux disease. Korean J. Neurogastroenterol. Motil. 9: 92-101.
- Pantoflickova, D., G. Dorta, M. Ravic, P. Jornod, and A. L. Blum (2003) Acid inhibition on the first day of dosing: comparison of proton pump inhibitors. Aliment Pharmacol. Ther. 17: 1507-1514. https://doi.org/10.1046/j.1365-2036.2003.01496.x
- Ia, H., H. Stenhoff, and M. Liljeblad (2007) Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry. J. Chromatogra. B. Analyt. Technol. Biomed. Life Sci. 848: 317-322. https://doi.org/10.1016/j.jchromb.2006.10.074
- Andersson, T., M. Hassan-Alin, G. Hasselgren, and K. Rohss (2001) Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Clin. Pharmacokinet. 40: 523-537. https://doi.org/10.2165/00003088-200140070-00004
- Shim, C. K., Y. H. Han, J. S. Woo, and C. H. Lee (1993) Effect of arginine of sodium phosphate dibasic on the stability of omeprazole in aqueous solution. J. Kor. Pharm. 4: 225-229.
- Zhang, X., N. Sun, B. Wu, Y. Lu, T. Guan, and W. Wu (2008) Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powder Technol. 182: 480-485. https://doi.org/10.1016/j.powtec.2007.07.011
- Ingmar, L. K., F. A. Gunnar, Y. Mitsuru, M. Satoshi, O. Minoru, and O. Naohiro (1987) Omeprazole preparation for oral use. KR Patent 19870004132.
- Tabata, T., T. Makino, J. Kikuta, S. Hirai, and N. Kitamori (1994) Manufacturing method of stable enteric granules of a new antiulcer drug (lansoprazole). Drug Dev. Ind. Pharm. 20: 1661-1672. https://doi.org/10.3109/03639049409050206
- Ho, H. O., H. L. Su, T. Tsai and M. T. Sheu (1996) The preparation and characterization of solid dispersions on pellets using a fluid bed system. Int. J. Pharm. 139: 223-229. https://doi.org/10.1016/0378-5173(96)04594-2
- US Pharmacopeia National Formulary (2003) USP 26-NF21. 3rd ed., pp. 2439. Mack Printing Company, Easton, USA.
- Ministry of Food and Drug Safety, Guideline on validation of analytical procedure. http://www.mfds.go.kr. (2015).
- Ministry of Food and Drug Safety, Guideline on bioequivalence test. http://nifds.go.kr. (2016).
- Yuksel, N., A. E. Kanik, and T. Baykara (2000) Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 209: 57-67. https://doi.org/10.1016/S0378-5173(00)00554-8
- Moore, J. W. and H. H. Flanner (1996) Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm. Tech. 20: 64-74.
- Shah, V. P., Y. Tsong, P. Sathe, and J. P. Liu (1998) In vitro dissolution profile comparison-statistics and analysis of similarity factor, f2. Pharm. Res. 15: 889-896. https://doi.org/10.1023/A:1011976615750
- Lee, Y. J., W. K. Whang, and S. W. Cho (2009) Effect of other medications on the stability of omeprazole in aqueous solution for the peptic ulcer disease. J. KAIS. 11: 3494-3499.
- Kim, Y. J. (1995) Stabilization of omeprazole by complexation with ethylenediamine. M.S. Thesis. Ewha Womans University, Seoul, Korea.
- Lee, E. J., K. D. Han, H. J. Shin, J. W. Kim and C. K. Kim (1997) Effect of L-arginine on the stability of omeprazole. J. Kor. Pharm. Sci. 27: 23-27
- Kumar, P. R., S. Shyale, M. M. Gouda, and S. M. S. Kumar (2011) Development of tablet formulation of enteric coated esomeprazole with Acrl EZE. Der Pharmacia Sinica. 2: 31-42.
-
$Nexium^{(R)}$ . http://www.rxlist.com/nexium-drug.htm. (2017). - Yoon, Y. N., S. J. Kim, S. H. Jung, H. J. Kim, E. S. Park, S. J. Hwang, Y. W. Lee, H. S. Seong, B. C. Chin, and S. H. Cho (2009) Pharmacokinetic evaluation and gastric ulcer symptoms comparison of ketorolac tromethamine sustained release pellets after oral administration in beagle dogs. J. Pharm. Sci. 39: 401-409.
- Ministry of Food and Drug Safety, Guideline on stability test. http://nifds.go.kr. (2014).